The UCLA TMS Clinical and Research Program offers state-of-the-art Transcranial Magnetic Stimulation (TMS) treatment for mood and anxiety disorders, as well as other neuropsychiatric illnesses. TMS is an FDA-approved treatment for patients with Major Depressive Disorder and Obsessive Compulsive Disorder who have not had an adequate response to medication treatment. In addition, TMS can be highly effective for patients with a variety of other illnesses including anxiety disorders, PTSD, chronic pain, tinnitus, among other conditions.
TMS treatment is extremely well tolerated with very few side effects. It can be used safely in combination with medications that a patient already may be receiving. TMS uses magnetic fields to influence brain networks, and its therapeutic benefits are thought to arise from “resetting” brain network function. This complementary approach to treatment offers new hope to many people whose symptoms have been resistant to treatment with medication or psychotherapy. The treatment is now widely acknowledged to be an evidence-based intervention for depression, and TMS is a covered benefit of most major health plans.
UCLA has been a leader in the TMS field since the founding of our program 10 years ago. We now operate six treatment rooms in which we perform more than 5,000 individual treatment sessions per year. Our team of seven faculty are Board-certified psychiatrists with broad expertise in a number of different areas, including:
All of our patients are seen at every treatment session by one of our faculty experts who will assess symptoms and adjust the treatment settings to obtain the maximum TMS treatment benefit as quickly as possible.
UCLA is a TMS provider under all major insurance plans, including Medicare. Our staff works with patients and referring physicians to obtain insurance approval prior to starting treatment. In order to be evaluated by one of our expert faculty, please click on the “Sign Up” link above.